Medicare Enrolled

Dr. Roger Febres, MD

Optician · Kissimmee, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
737 W OAK ST, Kissimmee, FL 34741
4079332775
In practice since 2014 (11 years)
NPI: 1982008033 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Febres from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Febres? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Febres

Dr. Roger Febres is an optician specialist in Kissimmee, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Febres performed 454 Medicare services across 215 unique beneficiaries.

Between the years covered by Open Payments, Dr. Febres received a total of $12,420 from 63 pharmaceutical and/or device companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Febres is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ 454 Medicare services $12,420 industry payments

Medicare Practice Summary

Medicare Utilization ↗
454
Medicare services
Bottom 26% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
215
Unique beneficiaries
$60
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~41 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 150 $90 $200
Complete blood count (CBC) with differential 77 $8 $30
Blood draw (venipuncture) 75 $8 $18
Hospital follow-up visit, high complexity 55 $94 $199
Comprehensive metabolic blood panel 43 $10 $18
Initial hospital admission, high complexity 28 $137 $586
New patient office visit (45-59 min) 26 $116 $485
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,420
Total received (2018-2024)
Avg $1,774/year across 7 years
Top 11% in FL for optician
63
Companies
604
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,164 (89.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,256 (10.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,923
2023
$1,807
2022
$2,127
2021
$1,712
2020
$664
2019
$2,661
2018
$1,525

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,649
PFIZER INC.
$1,324
Astellas Pharma US Inc
$1,076
Celgene Corporation
$694
E.R. Squibb & Sons, L.L.C.
$659
Seagen Inc.
$515
Janssen Biotech, Inc.
$470
Lilly USA, LLC
$458
GENZYME CORPORATION
$433
Exelixis Inc.
$431
AstraZeneca Pharmaceuticals LP
$333
Seattle Genetics, Inc.
$317
Incyte Corporation
$256
Merck Sharp & Dohme LLC
$254
NOVARTIS PHARMACEUTICALS CORPORATION
$249
GlaxoSmithKline, LLC.
$237
BeiGene USA, Inc.
$229
Amgen Inc.
$219
Takeda Pharmaceuticals U.S.A., Inc.
$178
Kite Pharma, Inc.
$165
Genentech USA, Inc.
$164
Daiichi Sankyo Inc.
$142
Gilead Sciences, Inc.
$112
Merck Sharp & Dohme Corporation
$109
Janssen Scientific Affairs, LLC
$105
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
Bayer Healthcare Pharmaceuticals Inc.
$99
ARRAY BIOPHARMA INC
$99
Alnylam Pharmaceuticals Inc.
$98
Bayer HealthCare Pharmaceuticals Inc.
$87
Stemline Therapeutics Inc.
$84
JAZZ PHARMACEUTICALS INC.
$73
ABBVIE INC.
$63
Karyopharm Therapeutics Inc.
$58
Regeneron Healthcare Solutions, Inc.
$55
Mirati Therapeutics, Inc.
$53
Clovis Oncology, Inc.
$52
Epizyme, Inc.,
$51
SOBI, INC
$50
EMD Serono, Inc.
$49
Global Blood Therapeutics, Inc.
$46
PUMA BIOTECHNOLOGY, INC.
$45
Deciphera Pharmaceuticals Inc.
$44
Kyowa Kirin, Inc.
$43
TerSera Therapeutics LLC
$39
ADC Therapeutics America, Inc.
$38
EUSA Pharma (US) LLC
$27
TAIHO ONCOLOGY, INC.
$27
Foundation Medicine, Inc.
$23
MACROGENICS, INC.
$21
EISAI INC.
$21
Blueprint Medicines Corporation
$20
Eisai Inc.
$20
G1 Therapeutics, Inc.
$19
Pharmacyclics LLC, An AbbVie Company
$18
CTI BioPharma Corp.
$18
ACCORD HEALTHCARE, INC.
$17
Alexion Pharmaceuticals, Inc.
$16
Puma Biotechnology, Inc.
$16
MorphoSys, US Inc.
$15
Verity Pharmaceuticals Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$13
INSYS Therapeutics Inc
$11
Top 3 companies account for 32.6% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Aliqopa · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CAMCEVI · COSELA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Inrebic · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MARGENZA · MEKINIST · MONJUVI · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TIVDAK · TUKYSA · Trelstar · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VYNDAQEL · Venclexta · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xtandi · Yescarta · ZEPZELCA · ZOLADEX · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,736 per 100 Medicare services performed
Looking for an optician specialist in Kissimmee?
Compare opticians in the Kissimmee area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
273
Per 100K population
67.1
County median income
$68,711
Nearest hospital
HCA FLORIDA OSCEOLA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Febres is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 11% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Febres experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Febres performed 150 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Febres receive payments from pharmaceutical companies?
Yes. Dr. Febres received a total of $12,420 from 63 companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Febres's costs compare to other opticians in Kissimmee?
Dr. Febres's average Medicare payment per service is $60. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Febres) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →